Research study Program year 2022 Source: CMS Open Payments

Nn9389-4606

Research payments

$31,485

4,572 payments

Through program year 2022, $31,485 in research payments was reported against Nn9389-4606, across 4,572 payments, paid by Novo Nordisk AS.

Paid by: Novo Nordisk AS
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$400	2
2021	Research	$31,085	4,570

Breakdown

Who paid Research payments · program years 2021–2022

Novo Nordisk AS $31,485 4,572 payments

Who received the money Research payments · program years 2021–2022

South Broward Research, LLC Organisation paid for research $2,864 317 payments
Consano Clinical Research, LLC Organisation paid for research $2,721 230 payments
Headlands Research, INC Organisation paid for research $2,298 292 payments
Dallas Diabetes And Endocrine Center Organisation paid for research $2,040 216 payments
Univ Of Tx Sw Med Center Organisation paid for research $1,601 216 payments
Cedar Crosse Research Center Organisation paid for research $1,509 177 payments
Velocity Clinical Research, INC Organisation paid for research $1,073 144 payments
Solaris Clinic Research Organisation paid for research $1,073 144 payments
Estudy Site Organisation paid for research $1,073 144 payments
National Research Institute Organisation paid for research $1,073 144 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.